Deficiency of the purinergic receptor P2X4 limits atherosclerosis in mice. (25th November 2020)
- Record Type:
- Journal Article
- Title:
- Deficiency of the purinergic receptor P2X4 limits atherosclerosis in mice. (25th November 2020)
- Main Title:
- Deficiency of the purinergic receptor P2X4 limits atherosclerosis in mice
- Authors:
- Koenig, S
Peikert, A
Merz, J
Rofa, K
Schaefer, I
Dimanski, D
Karnbrock, L
Von Garlen, S
Aleid, R
Bulatova, K
Hoppe, N
Bode, C
Zirlik, A
Stachon, P - Abstract:
- Abstract: Introduction: Extracellular nucleotides like ATP promote inflammation as danger signals in various chronic diseases via purinergic receptors. In our previous work we identified P2X4 expression in murine atherosclerotic lesions. Therefore, we hypothesized a contribution of the ATP-P2X4 axis to vascular inflammation in atherosclerosis. Methods: To investigate the functional role of P2X4 in atherogenesis, wild-type LDL-receptor deficient mice (LDLR−/−) and P2X4 -deficient LDLR−/− mice (P2X4 −/−LDLR−/−) were fed a high cholesterol diet for 16 weeks. Plaque progression in aortic arches was monitored by echography at intervals of 4 weeks, and leukocyte subsets in blood samples were analysed by flow cytometry. Atherosclerotic lesions were then assessed histologically in aortic root, arch, and abdominal aorta. In order to assess leukocyte recruitment, intravital microscopy was performed after injection of ATP in P2X4 −/− or wildtype mice (WT). Regarding transferability to human disease, atherosclerotic plaque from carotid endarterectomy has been stained immunohistochemically for P2X4 -receptor expression. Results: After 16 weeks, P2X4 -deficient mice showed significantly reduced atherosclerotic lesions in the aortic root (n=40, LDLR−/−: 0.47 mm 2, P2X4 −/−LDLR−/−: 0.39 mm 2, p=0.04). Ly6C- monocyte count in peripheral blood was higher in P2X4 −/−LDLR−/− (n=32, LDLR−/−: 241/μl, P2X4 −/−LDLR−/−: 542/μl, p=0.0088), shifting the balance to a more anti-inflammatory subset.Abstract: Introduction: Extracellular nucleotides like ATP promote inflammation as danger signals in various chronic diseases via purinergic receptors. In our previous work we identified P2X4 expression in murine atherosclerotic lesions. Therefore, we hypothesized a contribution of the ATP-P2X4 axis to vascular inflammation in atherosclerosis. Methods: To investigate the functional role of P2X4 in atherogenesis, wild-type LDL-receptor deficient mice (LDLR−/−) and P2X4 -deficient LDLR−/− mice (P2X4 −/−LDLR−/−) were fed a high cholesterol diet for 16 weeks. Plaque progression in aortic arches was monitored by echography at intervals of 4 weeks, and leukocyte subsets in blood samples were analysed by flow cytometry. Atherosclerotic lesions were then assessed histologically in aortic root, arch, and abdominal aorta. In order to assess leukocyte recruitment, intravital microscopy was performed after injection of ATP in P2X4 −/− or wildtype mice (WT). Regarding transferability to human disease, atherosclerotic plaque from carotid endarterectomy has been stained immunohistochemically for P2X4 -receptor expression. Results: After 16 weeks, P2X4 -deficient mice showed significantly reduced atherosclerotic lesions in the aortic root (n=40, LDLR−/−: 0.47 mm 2, P2X4 −/−LDLR−/−: 0.39 mm 2, p=0.04). Ly6C- monocyte count in peripheral blood was higher in P2X4 −/−LDLR−/− (n=32, LDLR−/−: 241/μl, P2X4 −/−LDLR−/−: 542/μl, p=0.0088), shifting the balance to a more anti-inflammatory subset. Memory-cell generation of CD4-T-cells is significantly higher in knockout-mice, suggesting an involvement of T-helper cells (n=25, LDLR−/−: 27%, P2X4 −/−LDLR−/−: 46%, p=0.0003). Peritoneally injected ATP induced leukocyte rolling in WT, but not in P2X4 -deficient mice. In human carotid arteries, atherosclerotic plaque shows higher staining for P2X4 −/− receptor than not diseased areas. Conclusion: P2X4 -deficiency enhances anti-inflammatory leukocytes in peripheral blood and reduces atherosclerosis. Therefore, blocking the ATP-P2X4 axis may prevent leukocyte recruitment to atherosclerotic lesions and could present a potential new target for anti-atherogenic therapy. Funding Acknowledgement: Type of funding source: Public grant(s) – National budget only. Main funding source(s): This work was supported by a research grant of the German Research Foundation (DFG) to Peter Stachon. Sebastian König was supported by a research grant of the German Cardiac Society (DGK) … (more)
- Is Part Of:
- European heart journal. Volume 41:(2020)Supplement 2
- Journal:
- European heart journal
- Issue:
- Volume 41:(2020)Supplement 2
- Issue Display:
- Volume 41, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 41
- Issue:
- 2
- Issue Sort Value:
- 2020-0041-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-11-25
- Subjects:
- Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Cardiology -- Periodicals
Heart -- Diseases -- Periodicals
616.12005 - Journal URLs:
- http://eurheartj.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/ehjci/ehaa946.3795 ↗
- Languages:
- English
- ISSNs:
- 0195-668X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.717500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26695.xml